Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 291-302

  Swerdlow, Neal R ^a   Shoemaker, Jody M ^a   Crain, Sarah ^a   Goins, Jana ^a   Onozuka, Kaori ^a   Auerbach, Pamela P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apomorphine; Dopamine; Phencyclidine; Prepulse inhibition; Schizophrenia startle; Strain

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; GENE MAPPING; GENETIC DIFFERENCE; HERITABILITY; INBRED STRAIN; MALE; NONHUMAN; OUTBRED STRAIN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; STARTLE REFLEX; STRAIN DIFFERENCE;

BUBALUS; RATTUS NORVEGICUS;

EID: 1642575179     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.11.008     Document Type: Article

References (32)

1. Braff D.L., Freedman R. The importance of endophenotypes in studies of the genetics of schizophrenia. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: the fifth generation of progress. 2002;703-716 Lippincott, Williams and Wilkins, Maryland.
2. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
3. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156:2001;234-258.
4. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: evidence of inhibitory deficits. Am. J. Psychiatry. 157:2000;1660-1668.
5. Castellanos F.X., Fine E.J., Kaysen D.L., Kozuch P.L., Hamburger S.D., Rapoport J.L.et al. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol. Psychiatry. 39:1996;33-41.
6. Drolet G., Proulx K., Pearson D., Rochford J., Deschepper C.F. Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains. Neuropsychopharmacology. 27:2002;400-409.
7. Ellenbroek B.A., Cools A.R. The neurodevelopment hypothesis of schizophrenia: clinical evidence and animal models. Neurosci. Res. Comm. 22:1998;127-136.
8. Enserink M. Fickle mice highlight test problems. Science. 284:1999;1599-1600.
9. Geyer M.A., Swerdlow N.R. Measurement of startle response, prepulse inhibition, and habituation. Crawley J., Skolnick P. Current protocols in neuroscience. 1998;1-15 Wiley, New York. unit 8.7.
10. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156:2001;117-154.
11. Glowa J.R., Hansen C.T. Differences in response to an acoustic startle stimulus among forty-six rat strains. Behav. Genet. 24:1994;79-84.
12. Graham F. The more or less startling effects of weak prestimuli. Psychophysiology. 12:1975;238-248.
13. Hitchcock J.M., Selk D.E., Wettstein J.G., Rush D.K. Intrastrain differences in the disruption of prepulse inhibition in rats by PCP, DOI, and 7-OH-DPAT. Schizophr. Res. 36:1999;115.
14. Kinney G.G., Wilkonson L.O., Saywell K.L., Tircklebank M.D. Rat strain differences in ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J. Neurosci. 19:1999;5644-5653.
15. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
16. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
17. Martinez Z.A., Halim N.D., Oostwegel J.L., Geyer M.A., Swerdlow N.R. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol. Biochem. Behav. 65:2000;449-457.
18. Palmer A.A., Dulawa S.C., Mottiwala A.A., Conti L.H., Geyer M.A., Printz M.P. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav. Neurosci. 114:2000;374-388.
19. Rigdon G. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology. 102:1990;419-421.
20. Rios M., Habecker B., Sasaoka T., Eisenhofer G., Tian H., Landis S.et al. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J. Neurosci. 19(9):1999;3519-3526.
21. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch. Gen. Psychiatry. 51:1994;139-154.
22. Swerdlow N.R., Varty G.B., Geyer M.A. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology. 18:1997;50-56.
23. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P.et al. Towards understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J. Neurosci. 20:2000;4325-4336.
24. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001;194-215.
25. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile pre-puff inhibition of startle in children with Tourette syndrome: in search of an "fMRI-friendly" startle paradigm. Biol. Psychiatry. 50:2001;578-585.
26. Swerdlow N.R., Platten A., Kim Y.K., Gaudet I., Shoemaker J., Pitcher L.et al. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants. Pharmacol. Biochem. Behav. 70:2001;219-226.
27. Swerdlow N.R., Shoemaker J.M., Pitcher L., Platten A., Kuczenski R., Eeley C.C.et al. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation. Behav. Neurosci. 116:2002;682-690.
28. Swerdlow N.R., Platten A., Hanlon F.M., Martinez Z.A., Printz M.P., Auerbach P. Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology. 28:2003;226-234.
29. Swerdlow N.R., Shoemaker J.M., Platten A., Pitcher L., Goins J., Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacol. Biochem. Behav. 75(1):2003;191-197.
30. Swerdlow N.R., Shoemaker J.M., Auerbach P.P., Pitcher L., Goins J., Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating: II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology. 2003;. [in press a].
31. Swerdlow N.R., Shoemaker J.M., Platten A., Pitcher L., Goins J., Auerbach P.P. Heritable differences in the dopaminergic regulation of sensorimotor gating: I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny. Psychopharmacology. 2003;. [in press b].
32. Varty G.B., Geyer M.A. Effects of isolation rearing on startle reactivity, habituation and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. Behav. Neurosci. 112:1998;1450-1457.